A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome

A 37‐year‐old woman developed persistent low‐grade fever (37.2°C) on day +13 after the first dose of BNT162b2 mRNA vaccine. She noticed coin‐sized hair loss on day +22, and it became widespread within 1 week. The patient's hair mostly recovered leaving only one oval bald patch on day +310 with...

Full description

Bibliographic Details
Main Authors: Yoshihiro Matsuda, Yoshio Kawakami, Masaya Kawamoto, Yoji Hirai, Shin Morizane
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Journal of Cutaneous Immunology and Allergy
Online Access:https://doi.org/10.1002/cia2.12292